Skip to content

AMSMNQ

L'imagerie personnalisée par la médecine nucléaire

  • Accueil
  • Mission
    • Mission de l’AMSMNQ
    • Mission du Comité de DPC de l’AMSMNQ
  • Qui Sommes Nous ?
    • Comité Exécutif
    • Comité du Développement Professionnel Continue (DPC)
    • Comité de la Radioprotection
    • Comité de la Tarification
    • Comité de l’Exercice Professionnel
    • Comité du Site Internet
  • Guide de Pratique
  • Journaux
  • Organisations
  • Partenaires
  • Accès DPC
  • Nous Joindre

    Partenaires

    Posted on 3 juin 20159 octobre 2018 by admin

    Hermes

    Lantheus

    Siemens Santé Limitée

    GE

    Covidien

    Jubilant-DraxImage

    Pharmalogic

    Philips

    Segami

    Cyclomedica

    Maranda-Lauzon

    Financières des Professionnels

    Sogemec

     

    • Prix AMSMNQ
      • Prix Genzyme
      • Prix Lantheus
      • Prix Financière des Professionnels
    • Colloque 2014 en photos
    • Colloque 2015 en photos
    • Colloque 2016 en photos
    • Colloque 2017 en photos
    • Colloque 2018 en Photos
    • Automnales
      • Automnale 2014 – L’infection
      • Automnale 2015 – Néoplasie de la Prostate

    Congrès et Colloque à venir

    RSS JNM en Primeur

    • Imaging of CAR T-cells in cancer patients - paving the way to treatment monitoring and outcome prediction 23 mai 2019
    • State of the Art PET/MRI: Applications and Limitations - Summary of the First ISMRM/SNMMI Co-Provided Workshop on PET/MRI 23 mai 2019
    • Should perfusion scintigraphy be done to follow patients with acute PE? If so, when? 23 mai 2019
    • PREDICTORS OF OVERALL AND DISEASE FREE SURVIVAL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS RECEIVING 225Ac-PSMA-617 RADIOLIGAND THERAPY 17 mai 2019
    • In vivo synaptic density imaging with 11C-UCB-J detects treatment effects of saracatinib (AZD0530) in a mouse model of Alzheimers disease. 17 mai 2019
    • 68Ga-pentixafor PET/CT for imaging of chemokine receptor-4 expression in Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma: comparison to 18F-FDG PET/CT 17 mai 2019
    • Improved Scatter Correction to Eliminate Halo-Artifacts for 68Ga-labeled Radiopharmaceuticals in PET Imaging 10 mai 2019
    • Imaging metastatic castration-resistant prostate cancer patients with 89Zr-DFO-MSTP2109A anti-STEAP1 antibody 10 mai 2019
    • Blocking Glucagon Like Peptide-1 Receptors in the Exocrine Pancreas Improves Specificity for Beta Cells in a Mouse Model of Type 1 Diabetes 10 mai 2019
    • Prospective evaluation of a tumor control probability model based on dynamic 18F-FMISO PET for head-and-neck cancer radiotherapy 10 mai 2019
    • Is there value for AI applications in molecular imaging and nuclear medicine? 3 mai 2019
    • Comparison of static 18F-FDG-PET/CT (SUV, SUR) and dynamic 18F-FDG-PET/CT (Ki) for quantification of pulmonary inflammation in acute lung injury 3 mai 2019
    • ImmunoPET to Optimize the Dose of Monoclonal Antibodies for Cancer Therapy - How Much is Enough? 3 mai 2019
    • Limits for reduction of acquisition time or administered activity in 18F-FDG PET studies in Alzheimers and frontotemporal dementia 26 avril 2019
    • Radiation dosimetry and biodistribution of 18F-PSMA-11 for PET imaging of prostate cancer 26 avril 2019

    Info-Lettre AMSMNQ

    Statistiques du Site

    • 0
    • 1
    • 1
    • 104 257

    Facebook AMSMNQ

     

    Copyright © 2019 : AMSMNQ | | Login

    Translate »